However, GLP-1 RA did not reduce the composite of hHF or CV death (HR 0.96, 95% CI 0.84 to 1.08) or ACM (HR 0.98, 95% CI 0.86 to 1.11) in the subgroup of patients with HF history. This evidence concerns the gene GLP1R and hydrops fetalis.